110 related articles for article (PubMed ID: 15765429)
1. Nonulcer dyspepsia and proton pump inhibitors.
Waldum HL; Martinsen TC; Brenna E
Gastroenterology; 2005 Mar; 128(3):805; author reply 805-6. PubMed ID: 15765429
[No Abstract] [Full Text] [Related]
2. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis.
Moayyedi P; Delaney BC; Vakil N; Forman D; Talley NJ
Gastroenterology; 2004 Nov; 127(5):1329-37. PubMed ID: 15521002
[TBL] [Abstract][Full Text] [Related]
3. NICE issues guidance for heartburn and indigestion.
Ferriman A
BMJ; 2000 Jul; 321(7255):197. PubMed ID: 10903645
[No Abstract] [Full Text] [Related]
4. Cost-effective prescribing of proton pump inhibitor therapy: an audit in general practice.
Cooper AL; Langworthy H; Porter S
Int J Clin Pract; 2000 Jun; 54(5):287-92. PubMed ID: 10954954
[TBL] [Abstract][Full Text] [Related]
5. [Dyspepsia and heartburn in primary care: a rational and economic approach].
Labenz J
MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
[No Abstract] [Full Text] [Related]
6. Yields of dual therapy containing high-dose proton pump inhibitor in eradication of H. pylori positive dyspeptic patients.
Ince AT; Tozlu M; Baysal B; Şentürk H; Arıcı S; Özden A
Hepatogastroenterology; 2014; 61(133):1454-8. PubMed ID: 25436324
[TBL] [Abstract][Full Text] [Related]
7. Dyspepsia management in primary care: a decision analysis of competing strategies.
Spiegel BM; Vakil NB; Ofman JJ
Gastroenterology; 2002 May; 122(5):1270-85. PubMed ID: 11984514
[No Abstract] [Full Text] [Related]
8. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
Bursey F; Crowley M; Janes C; Turner CJ
CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial.
Mason JM; Raghunath AS; Hungin AP; Jackson W
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1297-303. PubMed ID: 18793340
[TBL] [Abstract][Full Text] [Related]
10. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors for dyspepsia.
Vakil N
Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
[TBL] [Abstract][Full Text] [Related]
12. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
Smith T; Verzola E; Mertz H
Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
[TBL] [Abstract][Full Text] [Related]
13. Dyspepsia: is a trial of therapy appropriate?
Thompson WG
CMAJ; 1995 Aug; 153(3):293-9. PubMed ID: 7614445
[TBL] [Abstract][Full Text] [Related]
14. PPIs are therapeutically interchangeable and ideal for a managed care intervention such as therapeutic MAC.
Crownover BK
J Manag Care Pharm; 2006 Sep; 12(7):578-80. PubMed ID: 16981803
[TBL] [Abstract][Full Text] [Related]
15. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
[TBL] [Abstract][Full Text] [Related]
16. Yield of endoscopy in dyspepsia and concurrent treatment with proton pump inhibitors: the blind leading the blind?
Talley NJ
Gastrointest Endosc; 2003 Jul; 58(1):89-92. PubMed ID: 12838227
[No Abstract] [Full Text] [Related]
17. Do cost-effectiveness analyses cause you dyspepsia?
Ganiats TG
J Fam Pract; 1997 Jun; 44(6):541-2. PubMed ID: 9191625
[No Abstract] [Full Text] [Related]
18. Drug-induced Parkinsonism on the rise: Beware of levosulpiride and its combinations with proton pump inhibitors.
Mathew T; Nadimpally US; Prabhu AD; Nadig R
Neurol India; 2017; 65(1):173-174. PubMed ID: 28084264
[No Abstract] [Full Text] [Related]
19. Is nonulcer dyspepsia related to Helicobacter pylori infection?
Fennerty MB
Semin Gastrointest Dis; 2001 Jul; 12(3):180-5. PubMed ID: 11478750
[TBL] [Abstract][Full Text] [Related]
20. Rational prescribing: practice audit and drug switch in dyspepsia management.
Dott AG; Johnson L
Int J Clin Pract; 1999 Dec; 53(8):599-603. PubMed ID: 10692753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
